Characterization of long-term responders to first treatment course of rituximab (RTX) - Results from the CERERRA collaboration.

Elisabeth Lie, Katerina Chatzidionysiou, Evgeny L. Nasonov, Galina Lukina, Karel Pavelka, Dan C. Nordström, Matija Tomsic, Cem Gabay, Ioan Ancuta, Piet L.C. van Riel, Juan J. Gomez-Reino, João E. Fonseca, Merete Lund Hetland, Ulrik Tarp, Tore K. Kvien, Ronald F. van Vollenhoven

    OriginalsprogEngelsk
    TidsskriftArthritis & Rheumatism
    Vol/bind63
    Udgave nummer10 (Suppl.)
    Sider (fra-til)S877
    Antal sider1
    ISSN0004-3591
    StatusUdgivet - 2011

    Citationsformater